Innovation & Research Fund

The Urology Foundation will fund projects up to a value of £60,000 that seek to use new, exciting, innovative approaches to address urological diseases and disorders.

Innovation Fund

Innovation and Research Fund 2024

Applications for the 2024 fund are now closed. We received excellent applications and are currently reviewing and considering them.

If you have any queries about the application process, please email the office at grants@theurologyfoundation.org

What will we fund?

Our funding comes with the following provisions:

  • Research must be carried out in the UK or Ireland.
  • Applications are subject to rigorous review by our Review Panel and our Scientific and Education Committee.
  • Successful applicants must provide a satisfactory progress report to secure the final grant instalment. You’re also encouraged to submit abstracts to the British Association of Urological Surgeon’s (BAUS) Annual Meeting.

Please note that our Innovation and Research Fund is an individual award: the named applicant must be the person carrying out the research.

We are pleased to have funded the following projects in 2023:

Alasdair Hubbard Nottingham Trent University Clinically relevant study of antimicrobial resistance evolution in uropathogenic Escherichia coli using a model of the human bladder
Alan McWilliam University of Manchester / Christie Impact of body composition on patient outcomes in the STAMPEDE trial
Joseph Santiapillai UCL / Royal Free Hospital INVestigation Of Immune Priming Interventions in Kidney CancEr (INVOKE)
Kate Manley NNUH / UEA DESNT biomarker for the prediction of prostate cancer outcomes
Nikhil Mayor Imperial College London Ex vivo real-time analysis of radical prostatectomy margins using fluorescence confocal microscopy (FCM): are “digital frozen sections” the future?
Nikolitsa Nomikou University College London Augmenting the efficacy of sonodynamic therapy against metastatic castration-resistant prostate cancer
Priyanka Krishnaswamy University of Newcastle Oestrogen, DNA methylation and the susceptibility of post-menopausal women to recurrent urinary tract infections
Rebecca Hall University of Newcastle A Postal Pilot Study for a National Lynch Syndrome Urothelial Cancer Screening Programme based on Urine Analysis using the Newcastle MSI-Plus Assay